Login / Signup
Lorlatinib for the Treatment of ALK Fusion-Positive Infant-Type Hemispheric Glioma: A Case Report.
Alyssa M Greenwell
Scott Baughan
Deniz Altinok
Neena I Marupudi
William Kupsky
Chandan Kumar-Sinha
Hamza S Gorsi
Published in:
JCO precision oncology (2022)
Keyphrases
</>
advanced non small cell lung cancer
combination therapy
tyrosine kinase
epidermal growth factor receptor